# Skin Care Regimen for Improving Photoaging Signs on the Face

> **NCT06603857** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Goldman, Butterwick, Fitzpatrick and Groff** · enrollment: 40 (estimated)

## Conditions studied

- Improve Photoaging Signs

## Interventions

- **DRUG:** CE Ferulic
- **DRUG:** Sham Comparator
- **DEVICE:** 1927nm (Clear and Brilliant Perméa®)

## Key facts

- **NCT ID:** NCT06603857
- **Lead sponsor:** Goldman, Butterwick, Fitzpatrick and Groff
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-27
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-02-28
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06603857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06603857, "Skin Care Regimen for Improving Photoaging Signs on the Face". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06603857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*